Consequently, we have identified q-real-time PCR as a relatively reliable, convenient and inexpensive molecular diagnostic tool for deletion screening of FOXL2, which will facilitate genetic counseling for BPES patients and help identify those female patients who require an extended clinical follow-up for POF. The gene discussed is FOXL2; the disease is blepharophimosis, ptosis, and epicanthus inversus syndrome.